Treatment of pseudomonas infections in cystic fibrosis using tobramycin.
作者信息
McCrae W M
出版信息
Scott Med J. 1976 Apr;21(2):68-9. doi: 10.1177/003693307602100210.
PMID:940997
Abstract
摘要
相似文献
1
Treatment of pseudomonas infections in cystic fibrosis using tobramycin.
Scott Med J. 1976 Apr;21(2):68-9. doi: 10.1177/003693307602100210.
2
Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum.
J Infect Dis. 1976 Aug;134 Suppl:S191-3. doi: 10.1093/infdis/134.supplement_1.s191.
3
[Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
Ugeskr Laeger. 1979 Jul 16;141(29):1968-72.
4
Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
Med Lett Drugs Ther. 2014 Jun 23;56(1445):51-2.
5
Tobramycin inhalation powder (Tobi Podhaler) for cystic fibrosis.
Med Lett Drugs Ther. 2013 Jun 24;55(1419):51-2.
6
Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation.
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1089-90. doi: 10.1164/ajrccm.184.9.1089.
7
Long-term tobramycin therapy in patients with cystic fibrosis and advanced pulmonary disease.
Monogr Paediatr. 1979;10:31-3.
8
Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients.
Lancet. 2002 Feb 16;359(9306):626-7. doi: 10.1016/S0140-6736(02)07728-0.
9
Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
Lancet. 2001 Sep 22;358(9286):983-4. doi: 10.1016/S0140-6736(01)06124-4.
10
Inhaled tobramycin (TOBI).
Pediatr Nurs. 1998 May-Jun;24(3):258-9.
引用本文的文献
1
Tobramycin: a review of its antibacterial and pharmacokinetic properties and therapeutic use.
Drugs. 1976;12(3):166-200. doi: 10.2165/00003495-197612030-00002.
Zotero 插件